360° Coverage : Asthma drug that cures severe itchy rash

3 Updates
Asthma drug that cures severe itchy rash
Photo Credit: Spencer Platt, Getty Images

Asthma drug that cures severe itchy rash

Feb 24 2013, 10:08pm CST | by

Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a...

Filed under: news

YouTube Videos

 
 
 

1 year ago

Asthma drug that cures severe itchy rash

Feb 24 2013, 10:08pm CST | by

Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Known as omalizumab, the drug was tested on 323 people at 55 medical centres for whom standard antihistamine therapy failed to quell underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

"Physicians and patients may now have a fast, safe and well-tolerated treatment option to consider before prescribing even more antihistamines, which can be highly sedating," says Sarbjit (Romi) Saini, Johns Hopkins allergist and immunologist, and study co-investigator, the The New England Journal of Medicine reports.

The study, from 2009 to 2011, involved mostly women aged between 12 and 75 years. Each was randomly assigned to take one of three dosing regimens of omalizumab, or placebo, after which they were monitored through regular checkups for four months, according to a Johns Hopkins statement.

All of them had chronic hives (itchy bumps on the skin) and rash for at least six months, with many having suffered from the condition for more than five years.

"Patients suffering with this condition need more and better treatment options because chronic hives and rash are profoundly hard to treat and can be very debilitating," says Saini, associate professor at the Johns Hopkins University School of Medicine.

Saini, who has studied omalizumab since 2005, points out that fewer than half of those treated respond to traditional drug treatments with antihistamines. Saini says the new study results offer substantial evidence that this first injection treatment option not only works, but does so more safely than other drugs.

These findings were presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Antonio, Texas.

IANS

Source: IANS

 
Update
3

1 day ago

EYVoice: From Doctor To Entrepreneur To A Natural Cleaning Product Guru

Oct 23 2014 8:49am CDT | Source: Forbes Real Time

After working with hospital cleaning chemicals and disinfectants that caused skin irritations and made her asthma flare up, Dr. Ruth Oltjer realized there was a need for quality, allergen-free disinfectants. And thus, Chemi-Pharm ...
Source: Forbes Real Time   Full article at: Forbes Real Time
 

 
Update
2

7 weeks ago

Cipla launches copy of GSK's top asthma drug in Germany, Sweden

Sep 1 2014 8:03am CDT | Source: Business Standard

Cipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticas ...
Source: Business Standard   Full article at: Business Standard
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/8" rel="author">Luigi Lugmayr</a>
Luigi is the founding Chief Editor of I4U News and brings over 15 years experience in the technology field to the ever evolving and exciting world of gadgets. He started I4U News back in 2000 and evolved it into vibrant technology magazine.
Luigi can be contacted directly at ml@i4u.com. Luigi posts regularly on LuigiMe.com about his experience running I4U.

 

blog comments powered by Disqus

Latest stories

China launches test return orbiter for lunar mission
Beijing, Oct 24 (IANS) China launched an unmanned spacecraft early Friday to test technologies to be used in the Chang'e-5, a future probe that will conduct the country's first moon mission and return to the Earth.
 
 
Mali confirms first Ebola case
Bamako, Oct 24 (IANS) The first case of Ebola virus was reported in western Mali town of Kayes, the country's health ministry has said.
 
 
Unesco chief condemns murder of Paraguayan journalists
Paris, Oct 24 (IANS/EFE) Unesco Director-General Irina Bokova Friday condemned the murder of Paraguayan journalist Pablo Medina Velazquez and his assistant Antonia Maribel Almada Chamorro, who were shot dead Oct 16 near Curuguaty in southeastern Paraguay.
 
 
Kidney stones may increase bone fracture risk
Washington, Oct 24 (IANS) People, especially women, who develop kidney stones may be at increased risk of experiencing bone fractures, finds a research.
 
 
 

Latest from the Network

Second MERS case reported in Qatar
Doha, Oct 23 (IANS) A 43-year-old man in Qatar has tested positive for Middle East Respiratory Syndrome (MERS) in the second confirmed case of the deadly virus in 10 days, media reported Thursday. The patient had...
Read more on Business Balla
 
Two people die in Pakistan bomb blast
Islamabad, Oct 23 (IANS) At least two people were killed and 12 others injured in an explosion that took place in Pakistan's Balochistan province Thursday, media reported. The bomb was planted on a motorcycle, Dawn...
Read more on Politics Balla
 
Trott extends contract with Warwickshire till 2017
London, Oct 23 (IANS) England batsman Jonathan Trott, whose mental issues led to his abrupt departure from last winter's Ashes tour, has confirmed his successful comeback to competitive cricket by signing a new three-...
Read more on Sport Balla
 
Srikanth, Kashyap big movers in BWF rankings
Kuala Lumpur, Oct 23 (IANS) Indian men shuttlers Kidambi Srikanth and Parupalli Kashyap jumped seven places each in the latest Badminton World Federation (BWF) rankings released Thursday while Olympic bronze medallist...
Read more on Sport Balla
 
Alvin Stardust dead
London, Oct 23 (IANS) English singer Alvin Stardust died after a short illness. He was 72. Stardust's manager confirmed the news about his demise Thursday, reports mirror.co.uk. He was recently diagnosed with...
Read more on Celebrity Balla
 
Indian man reunited with family after 40 years
Dubai, Oct 23 (IANS) An Indian man, who had disappeared from his hometown in Kerala nearly 40 years ago, has been found by his family at a hospital in Dubai in the UAE, a newspaper report said. Now in his 60s, Abdulla...
Read more on Politics Balla
 
Srikanth, Kashyap, Saina rise in world rankings
Kala Lumpur, Oct 23 (IANS) Indian men shuttlers Kidambi Srikanth and Parupalli Kashyap jumped seven places each in the latest released Badminton World Federation (BWF) rankings Thursday while Olympic bronze medallist...
Read more on Sport Balla
 
Flintoff signs for Big Bash side Brisbane Heat
Brisbane, Oct 23 (IANS) Former England captain and all-rounder Andrew Flintoff, who retired from international cricket in 2009, Wednesday confirmed that he will play for Brisbane Heat in the Big Bash League (BBL) this...
Read more on Sport Balla
 
OPEC daily basket price falls again
Vienna, Oct 23 (IANS/WAM) The basket of 12 crude oils of the Organization of Petroleum Exporting Countries (OPEC) closed at $81.94 a barrel Wednesday compared to $82.09 Tuesday, the OPEC Secretariat said. The new OPEC...
Read more on Business Balla
 
Lopez to sign multi-million dollar deal?
Los Angeles, Oct 23 (IANS) Singer-actress Jennifer Lopez is reportedly in the final stages of securing a multi-million dollar deal to perform in Las Vegas. The 45-year-old is being offered $350,000 per show at The...
Read more on Celebrity Balla